<DOC>
	<DOCNO>NCT00741845</DOCNO>
	<brief_summary>This purpose study conduct double-blind , randomize , control clinical trial determine association intravaginal high dose metronidazole ( 750mg ) , intravaginal high dose metronidazole combine antifungal agent ( 750mg metronidazole + 200mg miconazole ) low dose ( 37.5mg ) intravaginal metronidazole , rate persistent bacterial vaginosis .</brief_summary>
	<brief_title>Prevention Persistence Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>woman 1840 yr old abnormal vaginal discharge malodor positive QuickVue test positive KOH whiff test Positive finding clue cell great equal 20 % wet mount Able give informed consent willing abstain alcohol 5 day therapy 1 day follow immunocompromised woman symptomatic VVC pregnancy positive pregnancy test menstruate breastfeed woman oral vaginal antifungal antimicrobial drug w/in past 2 wks woman MPC , PID</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>